Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence
- PMID: 20719215
- PMCID: PMC3141556
- DOI: 10.1071/SH09130
Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence
Abstract
This review article provides a conceptual framework for human papillomavirus (HPV) vaccine acceptance and adherence, with a focus on improving understanding of the sociocultural factors impacting vaccine adherence behaviour. We include a systematic review of the slowly expanding literature on HPV vaccine acceptability and uptake in developed nations, as well as the relatively few publications from poorer nations, where more than 80% of global cervical cancer related deaths occur and where the vaccine will probably have the largest impact. We suggest that this conceptual framework will not only improve our understanding of HPV vaccine uptake and adherence, but it may also guide future sociobehavioural research geared towards improving adherence to the HPV vaccine and other multi-step vaccines in a young population at risk for sexually transmissible infections.
Conflict of interest statement
None declared.
Figures
Similar articles
-
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3. Cochrane Database Syst Rev. 2018. PMID: 29740819 Free PMC article.
-
Knowledge of human papillomavirus and the human papillomavirus vaccine in European adolescents: a systematic review.Sex Transm Infect. 2016 Sep;92(6):474-9. doi: 10.1136/sextrans-2015-052341. Epub 2016 Jan 20. Sex Transm Infect. 2016. PMID: 26792088
-
Parents' knowledge, beliefs, acceptance and uptake of the HPV vaccine in members of The Association of Southeast Asian Nations (ASEAN): A systematic review of quantitative and qualitative studies.Vaccine. 2021 Apr 22;39(17):2335-2343. doi: 10.1016/j.vaccine.2021.03.049. Epub 2021 Mar 27. Vaccine. 2021. PMID: 33781598
-
Interventions targeted at women to encourage the uptake of cervical screening.Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3. Cochrane Database Syst Rev. 2021. PMID: 34694000 Free PMC article.
-
Two-dose schedules for human papillomavirus vaccine: Systematic review and meta-analysis.Vaccine. 2017 May 19;35(22):2892-2901. doi: 10.1016/j.vaccine.2017.03.096. Epub 2017 Apr 25. Vaccine. 2017. PMID: 28455170
Cited by
-
A qualitative analysis of factors influencing HPV vaccine uptake in Soweto, South Africa among adolescents and their caregivers.PLoS One. 2013 Aug 30;8(8):e72094. doi: 10.1371/journal.pone.0072094. eCollection 2013. PLoS One. 2013. PMID: 24023613 Free PMC article.
-
Uptake of human papillomavirus (HPV) vaccination in Hong Kong: Facilitators and barriers among adolescent girls and their parents.PLoS One. 2018 Mar 15;13(3):e0194159. doi: 10.1371/journal.pone.0194159. eCollection 2018. PLoS One. 2018. PMID: 29543839 Free PMC article.
-
"1-2-3 Pap" Intervention Improves HPV Vaccine Series Completion among Appalachian Women.J Commun. 2013 Feb;63(1):95-115. doi: 10.1111/jcom.12001. Epub 2013 Jan 10. J Commun. 2013. PMID: 26560123 Free PMC article.
-
Sentiment Analysis of Social Media on Childhood Vaccination: Development of an Ontology.J Med Internet Res. 2019 Jun 7;21(6):e13456. doi: 10.2196/13456. J Med Internet Res. 2019. PMID: 31199290 Free PMC article.
-
A home-school-doctor model to break the barriers for uptake of human papillomavirus vaccine.BMC Public Health. 2015 Sep 21;15:935. doi: 10.1186/s12889-015-2269-1. BMC Public Health. 2015. PMID: 26392084 Free PMC article.
References
-
- Muñoz N, Castellsagué X, de González AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006;24:1–10. - PubMed
-
- Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–27. doi: 10.1056/NEJMoa021641. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 MH069133-06A1/MH/NIMH NIH HHS/United States
- R01 MH069133/MH/NIMH NIH HHS/United States
- K23 087228/PHS HHS/United States
- R21 NR010474/NR/NINR NIH HHS/United States
- K24 MH087227/MH/NIMH NIH HHS/United States
- R21 MH083308/MH/NIMH NIH HHS/United States
- 3R01MH069133-06A1S1/MH/NIMH NIH HHS/United States
- 5R21NR010474-02/NR/NINR NIH HHS/United States
- R21 MH085557/MH/NIMH NIH HHS/United States
- R21MH085557-01A1/MH/NIMH NIH HHS/United States
- KL2 RR025757/RR/NCRR NIH HHS/United States
- R21MH083308-02/MH/NIMH NIH HHS/United States
- K23 MH087228/MH/NIMH NIH HHS/United States
- R21 083306/PHS HHS/United States
- K-24 87227/PHS HHS/United States
- KL2RR025757-01/RR/NCRR NIH HHS/United States
- R21 MH083306/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical